CLINICAL_TRIALS
trial_result
· 2020-10-14
Clinical Trial Update: Exploration of Pupil Dilation in Horner's Patients Taking Flomax [Phase 4]
Summary
Phase 4 clinical trial exploring pupil dilation in Horner's syndrome patients taking Flomax has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Denver Health and Hospital Authority | Conditions: Horner Syndrome | Phase 4 | Status: TERMINATED | Results posted: 2020-10-14